REMOVED: Short-chain acyl-CoA dehydrogenase gene mutation (319 C>T) presents with clinical heterogeneity and is candidate founder mutation in Ashkenazi Jewish population. | Mol Genet Metab;2007 Jan 17. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

BVS - MINISTÉRIO DA SAÚDE

Informação e Conhecimento para a Saúde

português

Localizar descritor de assunto Busca Avançada EVID@Easy

REMOVED: Short-chain acyl-CoA dehydrogenase gene mutation (319 C>T) presents with clinical heterogeneity and is candidate founder mutation in Ashkenazi Jewish population.

Tein, Ingrid; Elpeleg, Orly; Ben-Zeev, Bruria; Korman, Stanley H; Lossos, Alexander; Lev, Dorit; Lerman-Sagie, Tally; Vockley, Gerard; Berry, Gerard T; Lamhownah, Anne-Marie; Matern, Dieter; Roe, Charles R; Gregersen, Niels.

Afiliação

Tein I; Division of Neurology, Department of Pediatrics, Laboratory Medicine and Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, Ont., Canada M5G 1X8.

Mol Genet Metab ; 2007 Jan 17.

Article em En | MEDLINE | ID: mdl-17234443

Buscar no Google

Base de dados: MEDLINE Idioma: En Ano de publicação: 2007 Tipo de documento: Article

Buscar no Google

Base de dados: MEDLINE Idioma: En Ano de publicação: 2007 Tipo de documento: Article